396 related articles for article (PubMed ID: 26969765)
1. Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats.
Baranowska-Kuczko M; Kozłowska H; Kloza M; Karpińska O; Toczek M; Harasim E; Kasacka I; Malinowska B
Life Sci; 2016 Apr; 151():288-299. PubMed ID: 26969765
[TBL] [Abstract][Full Text] [Related]
2. The influence of DOCA-salt hypertension and chronic administration of the FAAH inhibitor URB597 on K
Kloza M; Baranowska-Kuczko M; Malinowska B; Karpińska O; Harasim-Symbor E; Kasacka I; Kozłowska H
Vascul Pharmacol; 2017 Dec; 99():65-73. PubMed ID: 29038048
[TBL] [Abstract][Full Text] [Related]
3. Enhanced function of inhibitory presynaptic cannabinoid CB1 receptors on sympathetic nerves of DOCA-salt hypertensive rats.
Toczek M; Schlicker E; Grzęda E; Malinowska B
Life Sci; 2015 Oct; 138():78-85. PubMed ID: 25921770
[TBL] [Abstract][Full Text] [Related]
4. Age-specific influences of chronic administration of the fatty acid amide hydrolase inhibitor URB597 on cardiovascular parameters and organ hypertrophy in DOCA-salt hypertensive rats.
Toczek M; Baranowska-Kuczko M; Grzęda E; Pędzińska-Betiuk A; Weresa J; Malinowska B
Pharmacol Rep; 2016 Apr; 68(2):363-9. PubMed ID: 26922540
[TBL] [Abstract][Full Text] [Related]
5. Beneficial Changes in Rat Vascular Endocannabinoid System in Primary Hypertension and under Treatment with Chronic Inhibition of Fatty Acid Amide Hydrolase by URB597.
Baranowska-Kuczko M; Kozłowska H; Kloza M; Harasim-Symbor E; Biernacki M; Kasacka I; Malinowska B
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34063297
[TBL] [Abstract][Full Text] [Related]
6. Chronic inhibition of fatty acid amide hydrolase by URB597 produces differential effects on cardiac performance in normotensive and hypertensive rats.
Pędzińska-Betiuk A; Weresa J; Toczek M; Baranowska-Kuczko M; Kasacka I; Harasim-Symbor E; Malinowska B
Br J Pharmacol; 2017 Jul; 174(13):2114-2129. PubMed ID: 28437860
[TBL] [Abstract][Full Text] [Related]
7. Hypertension and chronic inhibition of endocannabinoid degradation modify the endocannabinoid system and redox balance in rat heart and plasma.
Biernacki M; Malinowska B; Timoszuk M; Toczek M; Jastrząb A; Remiszewski P; Skrzydlewska E
Prostaglandins Other Lipid Mediat; 2018 Sep; 138():54-63. PubMed ID: 30201316
[TBL] [Abstract][Full Text] [Related]
8. Redox system and phospholipid metabolism in the kidney of hypertensive rats after FAAH inhibitor URB597 administration.
Biernacki M; Ambrożewicz E; Gęgotek A; Toczek M; Bielawska K; Skrzydlewska E
Redox Biol; 2018 May; 15():41-50. PubMed ID: 29197803
[TBL] [Abstract][Full Text] [Related]
9. Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD.
Fidelman S; Mizrachi Zer-Aviv T; Lange R; Hillard CJ; Akirav I
Eur Neuropsychopharmacol; 2018 May; 28(5):630-642. PubMed ID: 29519609
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats.
Biernacki M; Łuczaj W; Gęgotek A; Toczek M; Bielawska K; Skrzydlewska E
Toxicol Appl Pharmacol; 2016 Jun; 301():31-41. PubMed ID: 27086176
[TBL] [Abstract][Full Text] [Related]
11. The effects of chronic FAAH inhibition on myocardial lipid metabolism in normotensive and DOCA-salt hypertensive rats.
Polak A; Harasim-Symbor E; Malinowska B; Kasacka I; Pędzińska-Betiuk A; Weresa J; Chabowski A
Life Sci; 2017 Aug; 183():1-10. PubMed ID: 28633967
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats.
Nucci C; Gasperi V; Tartaglione R; Cerulli A; Terrinoni A; Bari M; De Simone C; Agrò AF; Morrone LA; Corasaniti MT; Bagetta G; Maccarrone M
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2997-3004. PubMed ID: 17591864
[TBL] [Abstract][Full Text] [Related]
13. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
Maione S; Bisogno T; de Novellis V; Palazzo E; Cristino L; Valenti M; Petrosino S; Guglielmotti V; Rossi F; Di Marzo V
J Pharmacol Exp Ther; 2006 Mar; 316(3):969-82. PubMed ID: 16284279
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of receptor types mediating the dilator action of anandamide on blood vessels of the rat knee joint.
Lam FF; Luk PW; Ng ES
Life Sci; 2007 Mar; 80(16):1495-502. PubMed ID: 17275857
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
Herradón E; Martín MI; López-Miranda V
Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats.
Forget B; Guranda M; Gamaleddin I; Goldberg SR; Le Foll B
Psychopharmacology (Berl); 2016 May; 233(10):1823-8. PubMed ID: 26864774
[TBL] [Abstract][Full Text] [Related]
17. Modulation by 17β-estradiol of anandamide vasorelaxation in normotensive and hypertensive rats: a role for TRPV1 but not fatty acid amide hydrolase.
Ho WS
Eur J Pharmacol; 2013 Feb; 701(1-3):49-56. PubMed ID: 23340220
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Long-Term Administration of Fatty Acid Amide Hydrolase Inhibitor URB597 on Oxidative Metabolism in the Heart of Rats with Primary and Secondary Hypertension.
Biernacki M; Łuczaj W; Jarocka-Karpowicz I; Ambrożewicz E; Toczek M; Skrzydlewska E
Molecules; 2018 Sep; 23(9):. PubMed ID: 30223427
[TBL] [Abstract][Full Text] [Related]
19. Effects of the FAAH inhibitor, URB597, and anandamide on lithium-induced taste reactivity responses: a measure of nausea in the rat.
Cross-Mellor SK; Ossenkopp KP; Piomelli D; Parker LA
Psychopharmacology (Berl); 2007 Feb; 190(2):135-43. PubMed ID: 17111174
[TBL] [Abstract][Full Text] [Related]
20. Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats.
Ho WS; Gardiner SM
Br J Pharmacol; 2009 Jan; 156(1):94-104. PubMed ID: 19133994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]